High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
Funding Amount
Varies
Deadline
March 6, 2027
159 days left
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Public colleges & universities
- School districts
- Small businesses
- Nonprofits (501(c)(3))
- For-profit businesses
- Special district governments
- County governments
- Tribal governments
Other requirements
- Territory or Possession.
Overview
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: RFA-DA-25-024
- Instrument: grant
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
How to Apply
RFA-DA-25-024 Full Announcement Text
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta http-equiv="refresh" content="0; URL='http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-024.html'" />
<title>RFA-DA-25-024</title>
</head>
<body>
</body>
</html>
Focus Areas & Funding Uses
Fields of Work
- Science research
- HIV/AIDS
- Addiction recovery
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Renewal of the Clinician-Scientists Transdisciplinary Aging Research (Clin-STAR) Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $1.5M
Deadline
September 29, 2026
NIDCD's Mentored Research Education Pathway for Otolaryngology Residents and Medical Students (R25 - Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $499,999
Deadline
September 29, 2026
Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed)
National Institutes of Health
Amount
$3,745,000 total
Deadline
September 30, 2026
Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $3,300,000
Deadline
September 30, 2026
Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$3,000,000 total
Deadline
September 30, 2026
Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$2,000,000 total
Deadline
September 30, 2026
Ready to apply for High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found High Priority HIV and Substance Use Research (R01 Clinical Trial Optional). Now let's win it.